CAMA members are front runners in the fight against malaria. Their activities span the full spectrum of public health interventions including the development of product innovations to fight malaria such as bed nets, implementation of vector control measures such as Indoor Residual Spraying in communities, provision of treatment to families and pregnant women and guidance on policy frameworks and investments at institutions such as the Global Fund, RBM and Swiss Tropical Health Institute.

CAMA membership is structured into two levels—Leadership Council and Affiliate Group. Membership dues support Alliance management and nominal activities as agreed within the work plan. Members typically go above and beyond their dues contribution by also supporting specific work streams or activities based on their areas of interest.

While CAMA is focused first and foremost on mobilizing the private sector in the malaria fight, non-profit institutions may contribute to CAMA through membership, technical support on areas as defined by the Alliance and/or activities at a global or in-country level.

Learn how you can join CAMA by downloading the CAMA Participation and Benefits Flyer. Or, contact us to see how your organization can become an official CAMA Partner.

Leadership Council

Access Bank Plc Access Bank Plc has over the years consistently demonstrated a sincere commitment to sustainability principles across its various operations and its core business functions becoming more integral to the Access Bank strategic business objectives. Learn more about Access Bank’s community initiatives here.
Chevron Corporation Chevron Corporation‘s anti-malarial programs are based on the ABCD strategy: Awareness (education and advocacy), Bite prevention, Chemoprophylaxis and Diagnosis. Chevron’s efforts to combat malaria occur at the regional and local business level through corporate partnerships with governments, business, NGO’s and multilateral agencies. Learn more about how Chevron engages in community health issues here.
Aliko Dangote Foundation is the Corporate Social Responsibility arm of the Dangote Group, one of the most diversified business conglomerates in Africa headquartered in Lagos, Nigeria. Learn more about Dangote Foundation’s community investments here.
ExxonMobil ExxonMobil‘s is involved in a wide range of global initatives and partners with many organizations to prevent, treat and find a cure for malaria. ExxonMobil’s partnerships with the world’s leading organizations working on the front-lines in the fight against malaria provide education, prevention, diagnosis and research. Find out more about ExxonMobil’s malaria initiatives.

Affiliate Group


  Bayer has been a leader in malaria prevention for over 60 years and offers a unique and comprehensive vector control portfolio. In addition to pharmaceutical products, insecticide-treated nets and indoor residual spraying products form a major part of Bayer’s fight against malaria. Learn more about Bayer’s involvement here.
Nigerian Breweries Plc  Nigerian Breweries Plc. has made the prevention and treatment of malaria in its employees a top priority. The number of reported cases of malaria in employees and family members has steadily been decreasing in past years.
nlng  Nigeria LNG has successively partnered with the Rivers State Government to implement “Roll Back Malaria” programs comprising of awareness programs, donation of over 15,000 Long Lasting Insecticide Nets and educating families on the correct use of the nets. Learn more about Nigeria LNG’s community health campaigns here.
Sumitomo-Chemical Sumitomo Chemical has a comprehensive approach to vector control that includes Integrated Vector Management (IVM).  Notable among the company products are the Olyset™ Net which was the first LLIN to receive full WHOPES recommendation, SumiLarv® 0.5 G, an advanced mosquito larval control agent and SumiPro™, a new space sprayLearn more about Sumitomo Chemical’s contributions to the fight against malaria here. 
Web-Logo Syngenta’s corporate goals include those dedicated to the improvement of health and quality of life. Syngenta’s Vector Control business delivers this commitment by playing a role in the prevention of vector-borne disease transmission through modern insecticide technology in the brands ICON® and ACTELLIC®. Learn more about Syngenta and vector management here.


An important part of CAMA’s mandate is to provide a forum for business to engage with and build relations with malaria-focused government and civil society stakeholders. CAMA works with leading global institutions to enable cross-sector partnership building. Alliance partners include:

The Roll Back Malaria Partnership (RBM)

RBM brings together donors, malaria endemic countries, development partners, NGOs, foundations and research and academic institutions from across the world to address the malaria epidemic. GBCHealth serves the role of  Focal Point to the Private Sector Constituency of RBM, coordinating and facilitating the private sector’s interaction with the RBM Secretariat and its mechanisms.

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Over the past decade, the Global Fund to Fight AIDS, Tuberculosis and Malaria has helped save millions of lives around the world. The private sector has played a vital role in this private-public partnership. GBCHealth serves the role of Focal Point for the Private Sector Delegation (PSD), providing an entry-point for private sector collaboration with the Global Fund and overseeing, managing and coordinating the PSD.

Office of the U.N. Secretary-General’s Special Envoy for Financing the Health Millennium Development Goals and for Malaria 

GBCHealth’s offices are co-located with the Office of the U.N. Secretary-General’s Special Envoy for Financing the Health MDGs and for Malaria (UNSEO) and the affiliated special initiative, the MDG Health Alliance.  This co-location facilitates close collaboration between GBCHealth, CAMA and the UNSEO, and allows each to tap into the other’s public and private sector resources to maximize impact. Ray Chambers, the UN Special Envoy for Financing the Health MDGs and for Malaria is also GBCHealth’s Board Co-Chair.